Suppr超能文献

Feasibility and safety of two weeks of blood flow restriction exercise in individuals with spinal cord injury.

作者信息

Jønsson Anette Bach, Krogh Søren, Severinsen Kåre Eg, Aagaard Per, Kasch Helge, Nielsen Jørgen Feldbæk

机构信息

Spinal Cord Injury Center of Western Denmark, Viborg, Denmark.

Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.

出版信息

J Spinal Cord Med. 2024 Oct 11:1-10. doi: 10.1080/10790268.2024.2408052.

Abstract

CONTEXT

Reduced muscle strength and function are common after spinal cord injury (SCI). While low-load blood flow restriction exercise (BFRE) enhances muscle strength in healthy and clinical populations, its safety and feasibility in individuals with SCI remain underexplored.

OBJECTIVES

To investigate the feasibility and safety of low-load BFRE in individuals with incomplete SCI.

STUDY DESIGN

Case series.

SETTING

SCI rehabilitation center.

PARTICIPANTS

Six participants with motor incomplete SCI were enrolled in the study.

INTERVENTION

A two-week BFRE intervention for the lower limbs was conducted twice weekly at 40% total arterial occlusion pressure, using 30-40% of 1-repetition maximum loads.

OUTCOME MEASURES

Feasibility measures, specifically recruitment and eligibility rates and intervention acceptability, were collected. Blood pressure (BP) responses and specific coagulation markers for deep vein thrombosis (DVT) were assessed as safety measures.

RESULTS

Recruitment and eligibility rates were 2.8% and 6.6% for individuals admitted for first-time rehabilitation (subacute SCI) and 8.3% and 13.9% for 4-week readmission rehabilitation stays (chronic SCI), respectively. Intervention acceptability was high, characterized by 95.8% training adherence and low-to-moderate self-reported pain levels. BP responses and changes in C-reactive protein, Fibrinogen, and D-dimer during the intervention remained within clinically acceptable levels.

CONCLUSION

BFRE was feasible in an SCI rehabilitation setting despite a low recruitment rate. BFRE imposed no heightened risk of DVT or severe BP fluctuations in the present case series. Additionally, no severe adverse events occurred, and only mild complaints were reported. More extensive safety considerations warrant larger-scale exploration.

TRIAL REGISTRATION

ClinicalTrials.gov identifier: NCT03690700.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验